Canada Life
TEVA icon

Canada Life’s Teva Pharmaceuticals TEVA Stock Holding History

Canada Life’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.1M Sell
568,100
-8,993
-2% -$289K 0.03% 408
2025
Q4 		$18M Sell
577,093
-28,753
-5% -$708K 0.03% 396
2025
Q3 		$11.6M Buy
605,846
+3,423
+0.6% +$60.1K 0.02% 541
2025
Q2 		$10.1M Sell
602,423
-65,506
-10% -$1.06M 0.02% 540
2025
Q1 		$10.3M Sell
667,929
-30,048
-4% -$537K 0.02% 548
2024
Q4 		$15.4M Buy
697,977
+126,425
+22% +$2.3M 0.03% 469
2024
Q3 		$10.3M Buy
571,552
+35,624
+7% +$623K 0.02% 568
2024
Q2 		$8.71M Buy
535,928
+55,629
+12% +$857K 0.02% 594
2024
Q1 		$6.78M Buy
480,299
+98,710
+26% +$1.24M 0.01% 674
2023
Q4 		$3.97M Sell
381,589
-346,215
-48% -$3.23M 0.01% 886
2023
Q3 		$7.42M Buy
727,804
+371,180
+104% +$3.46M 0.02% 591
2023
Q2 		$2.69M Sell
356,624
-145,805
-29% -$1.18M 0.01% 1039
2023
Q1 		$4.45M Buy
502,429
+4,537
+0.9% +$44.9K 0.01% 805
2022
Q4 		$4.56M Buy
497,892
+64,344
+15% +$561K 0.01% 776
2022
Q3 		$3.49M Sell
433,548
-23,727
-5% -$210K 0.01% 843
2022
Q2 		$3.44M Buy
457,275
+36,742
+9% +$320K 0.01% 854
2022
Q1 		$4.14M Buy
420,533
+16,134
+4% +$135K 0.01% 836
2021
Q4 		$3.23M Buy
404,399
+64,366
+19% +$581K 0.01% 943
2021
Q3 		$3.33M Buy
340,033
+24,978
+8% +$234K 0.01% 866
2021
Q2 		$3.12M Sell
315,055
-5,179
-2% -$54.8K 0.01% 882
2021
Q1 		$3.68M Buy
320,234
+17,108
+6% +$196K 0.01% 803
2020
Q4 		$2.92M Sell
303,126
-193,012
-39% -$1.85M 0.01% 954
2020
Q3 		$4.46M Buy
496,138
+83,728
+20% +$886K 0.01% 757
2020
Q2 		$5.07M Sell
412,410
-38,836
-9% -$439K 0.01% 685
2020
Q1 		$4.07M Buy
451,246
+70,929
+19% +$727K 0.01% 692
2019
Q4 		$3.7M Sell
380,317
-177,722
-32% -$1.59M 0.01% 817
2019
Q3 		$3.84M Sell
558,039
-92,244
-14% -$707K 0.01% 727
2019
Q2 		$5.99M Buy
650,283
+64,664
+11% +$780K 0.01% 675
2019
Q1 		$9.16M Buy
585,619
+157,429
+37% +$2.78M 0.02% 514
2018
Q4 		$6.27M Buy
428,190
+12,515
+3% +$257K 0.02% 585
2018
Q3 		$8.96M Sell
415,675
-55,789
-12% -$1.3M 0.02% 539
2018
Q2 		$11.5M Buy
471,464
+73,050
+18% +$1.49M 0.03% 503
2018
Q1 		$6.82M Sell
398,414
-2,179
-0.5% -$42.5K 0.02% 639
2017
Q4 		$7.58M Buy
400,593
+25,800
+7% +$388K 0.02% 614
2017
Q3 		$6.42M Buy
374,793
+3,127
+0.8% +$70.4K 0.02% 636
2017
Q2 		$12.3M Sell
371,666
-444,582
-54% -$13.8M 0.03% 447
2017
Q1 		$26.2M Buy
816,248
+143,401
+21% +$4.89M 0.07% 267
2016
Q4 		$24.5M Buy
672,847
+666,315
+10,201% +$26.6M 0.07% 278
2016
Q3 		$302K Sell
6,532
-4,199
-39% -$219K ﹤0.01% 1802
2016
Q2 		$533K Hold
10,731
– – ﹤0.01% 1631
2016
Q1 		$574K Hold
10,731
– – ﹤0.01% 882
2015
Q4 		$706K Hold
10,731
– – ﹤0.01% 857
2015
Q3 		$603K Sell
10,731
-66,291
-86% -$4.3M ﹤0.01% 853
2015
Q2 		$4.55M Sell
77,022
-2,100
-3% -$130K 0.02% 649
2015
Q1 		$4.91M Sell
79,122
-368
-0.5% -$21.4K 0.02% 628
2014
Q4 		$4.58M Sell
79,490
-20,660
-21% -$1.15M 0.02% 635
2014
Q3 		$5.38M Sell
100,150
-33,175
-25% -$1.76M 0.02% 585
2014
Q2 		$6.97M Sell
133,325
-13,110
-9% -$670K 0.02% 513
2014
Q1 		$7.7M Sell
146,435
-9,600
-6% -$444K 0.03% 475
2013
Q4 		$6.27M Sell
156,035
-70,545
-31% -$2.78M 0.02% 523
2013
Q3 		$8.55M Sell
226,580
-124,068
-35% -$4.84M 0.03% 422
2013
Q2 		$13.8M Buy
+350,648
New +$13.7M 0.09% 184

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canada Life's TEVA Position: Q1 2026 in Review

Canada Life reduced its Teva Pharmaceuticals (TEVA) stake by 1.6% in Q1 2026, selling an estimated $289K and leaving 568,100 shares worth $17.1M. The position accounts for 0.03% of the portfolio, ranked #408.

Canada Life first reported a position in TEVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $26.2M in Q1 2017. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Canada Life held 568,100 shares of Teva Pharmaceuticals worth $17.1M as of Q1 2026.
  • Canada Life sold 8,993 Teva Pharmaceuticals shares in Q1 2026, an estimated $289K.
  • Teva Pharmaceuticals made up 0.03% of Canada Life's portfolio in Q1 2026, its #408 holding.
  • Canada Life first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Canada Life's Teva Pharmaceuticals position peaked at $26.2M in Q1 2017.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.